FCMI
NVAX icon

Foresite Capital Management I’s Novavax NVAX Stock Holding History

Foresite Capital Management I’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-100
Closed -$906K – 10
2014
Q1 		$906K Sell
100
-225
-69% -$25.1K 0.64% 10
2013
Q4 		$16K Buy
+325
New +$23K 0.02% 9

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Foresite Capital Management I's NVAX Position: Q4 2021 in Review

Foresite Capital Management I sold out of Novavax (NVAX) in Q4 2021, closing a stake of 66,810 shares — an estimated $13.8M sold.

Foresite Capital Management I first reported a position in NVAX in Q4 2013 and held it in 7 quarters. The position peaked at $14.2M in Q2 2021. 429 funds tracked by Wall St. Rank hold NVAX as of Q4 2021.

  • Foresite Capital Management I reported no remaining Novavax position as of Q4 2021 after selling out during the quarter.
  • Foresite Capital Management I sold 66,810 Novavax shares in Q4 2021, an estimated $13.8M.
  • Foresite Capital Management I first reported a position in Novavax in Q4 2013 and held it in 7 quarters.
  • Foresite Capital Management I's Novavax position peaked at $14.2M in Q2 2021.
  • 429 funds tracked by Wall St. Rank held Novavax as of Q4 2021.

Based on Foresite Capital Management I's 13F filing for Q4 2021, filed 11 Feb 2022.